GLP-1 drugs are 36% more effective than aspirin in reducing colorectal cancer risk, with fewer side effects like acute kidney ...

As global regulators rethink tobacco control strategies, the U.S. FDA’s move toward a “chain of risk” framework has sparked ...

Prediction markets are pricing 40 percent odds of a Greenland takeover, driven by Arctic security, Starlink connectivity, ...

BBAI slashes $125M in convertible debt, easing financial strain and potentially resetting its valuation outlook.

In the third quarter, U.S. stocks extended a historically fast rebound that began in early April. Read more here.

A prominent housing economist who performs market studies nationwide weighs in on the new home market and the apartment and ...

In the third quarter, U.S. stocks extended a historically fast rebound that began in early April. Read more here.

It has switched to a bespoke MSCI Climate Action Index to reduce portfolio concentration while continuing to support the ...

If you’re hunting for yield in 2026, emerging market bonds just became more interesting. The iShares J.P. Morgan USD Emerging Markets Bond ETF (NYSEARCA:EMB) offers a 5.5% dividend yield as the asset ...

Early intensive BP control significantly reduces cardiovascular risk in older patients compared with delayed initiation of treatment.

With data as of January 2, 2026, we examine if Forafric Global PLC(AFRI) is consistently building momentum based on AAII's A+ Investor Momentum and Value Scores and Grades.

The Food and Drug Administration (FDA) has approved Rybrevant Faspro™, a subcutaneous (SC) formulation of amivantamab for all indications approved for the ...